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CASE REPORT 
Leptospirosis – the unsuspecting culprit 
a case report and literature review  
Sarah Bigeni, Andrea Brincat, Josephine Bigeni
Leptospirosis is caused by spirochete bacteria in the genus 
Leptospira and can present with a vast range of clinical symptoms.  
We report a case of leptospirosis in a 47-year-old gentleman who 
presented with sepsis and ended up with multi-organ failure.  He was 
treated with piperacillin/tazobactam and doxycycline was added at a 
later stage.  The patient recovered well with no complications.  A 
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INTRODUCTION 
Leptospirosis is a worldwide public health 
problem with 1.03 million annual cases 
worldwide per year.1 Patients with 
leptospirosis may present with predominant 
pulmonary symptoms, ranging from cough, 
chest pain, breathlessness and mild to severe 
haemoptysis to acute respiratory distress 
syndrome (ARDS).  The pulmonary symptoms 
usually appear between the fourth and sixth 
day of illness.  The evolution of the disease 
may be very rapid and may result in death in 
less than 72 hours.2 The patient can also 
present with kidney and liver failure.  
Leptospira bacteria are excreted in bodily 
fluids including urine and then penetrate their 
host through abrasions in the skin or via the 
mucosal membrane.  There are a lot of 
peridomestic animals (rats, horses, cows, dogs, 
and pigs) and feral animals (bats, coyotes, sea 
lions, and even frogs) that can 
carry Leptospira bacteria in their kidneys.  
These animals are then presumed to excrete 
Leptospira in the environment.1 Occupations 
that have direct (including veterinarian and 
farmer) or indirect (such as plumbing or sewer 
worker) contact with animal excrete are at risk 
of contacting Leptospira.2 
CASE REPORT 
A 47-year-old, Gozitan man suffering from 
diabetes mellitus presented to the Accident 
and Emergency Department with sepsis.  He 
complained of a three-day history of lethargy, 
nausea, vomiting, loose stools, 24 hours of 
fever, decreasing appetite and oral intake. He 
also had myalgia, especially over his right 
shoulder and chest.  He denied any recent 
travel.  However, on further questioning, he 
claimed to work in the fields daily and was 
noted to have several abrasions.  The patient 
was a non-smoker and only drank alcohol 
socially. 
Vital signs in the emergency department were 
notable for a blood pressure of 106/63mmHg 
which decreased to 85/46mmHg within an 
hour and tachycardia at 130bpm.  The patient 
was alert and orientated.  The ocular 
examination was notable for scleral icterus.  
The skin appeared jaundiced, however, an 
examination of the heart, lungs, abdomen and 
lower limbs were unremarkable. 
INITIAL LABORATORY STUDY RESULTS  
The initial blood test results are shown in Table 
1.  Chest radiography was normal and 
electrocardiography showed sinus tachycardia 
at 134 beats/min. 
The patient was admitted to the intensive care 
unit for sepsis shock and multiorgan 
dysfunction.  Intravenous 
piperacillin/tazobactam was initiated with 
aggressive fluid resuscitation together with 
noradrenaline as inotropic support. 
The following day, he was still dehydrated.  
Chest auscultation revealed few sparse basal 
crackles, the abdomen was slightly tender in 
the epigastric area but there was no 
guarding/rebound.  Serologic test results for 
acute hepatitis A, B and C infections were 
negative.  An abdominal ultrasound showed 
hepatosplenomegaly.  Doxycycline was added 
to piperacillin/tazobactam. 
Day 2 post-admission, there was bronchial 
breathing on the right base and CXR confirmed 
a mild consolidation in the right lung middle 
field.  His CRP increased from 200mg/L to 
423mg/L and platelets decreased from 118 
x109/L to 96 x109/L.  Results also came back 
positive for the legionella urinary antigen. 
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Day 3 post-admission, his general condition 
improved.  His CRP decreased from 300mg/L 
to 197mg/L.  Serum Leptospira IgM came back 
as positive so leptospirosis was confirmed. 
Day 4 post-admission, his oxygen saturation 
dropped to 88% on air.  He was given 7L/min 
oxygen via a normal mask which kept his 
oxygen saturations at 96%.  Bronchial 
breathing in the right base persisted.  He was 
restarted on metformin which was stopped 
during admission. 
 
Table 1 Initial blood test results 
Investigation  Normal range 
White blood cell count 7.3 x 109/L 4.3 - 9.43 x109/L 
Haemoglobin 15.4g/dL 14.1 - 17.2g/dL 
Platelets 115 x 109/L 146 - 302 x 109/L 
CRP 200mg/L 0 - 5 mg/L 
Sodium 125mmol/L 135 - 145mmol/L 
Creatinine 117umol/L 62 - 106umol/L 
Bilirubin 66.5umol/L 0 - 17.1umol/L 
Alkaline phosphotase (ALP) 72U/L 40 - 129U/L 
Aspartate aminotransferase 
(AST) 
118U/L 10 - 50U/L 
 
Day 5 post-admission, he maintained his blood 
pressure and inotropic support could be 
stopped.  A chest X-ray showed deterioration 
in the right lung.  The consolidation had 
increased in size involving almost the whole 
right lung.  There was a mild right pleural 
effusion and there was also a new 
consolidation in the left lung (Figure 1). 
Day 6 post-admission, he was clinically stable 
but developed respiratory distress.  A 
diagnosis of acute respiratory distress 
syndrome was made and non-invasive 
ventilation was started.  CRP continued to 
decrease from 50mg/L to 39mg/L.  Computed 
tomography of the thorax showed the 
presence of many consolidations commencing 
from upper lobes and involving both lower 
lobes bilaterally associated with bilateral 
pleural effusions (right more than left).  There 
were bulky mediastinal and enlarged hilar 
lymph nodes.  There was some oedema of the 
right axilla and right chest wall. The spleen was 
seen to be enlarged (16x10cm). The CT 
imaging was very suggestive of leptospirosis 
(Figure 2.) 
The clinical picture demonstrated that he was 
responding to treatment.  He was continued 
on piperacillin/tazobactam 4.5g TDS for a total 
of 10 days and doxycycline 100mg BD for a 
total of 7 days.  Despite the deterioration after 
an initial improvement, he did well and 
recovered fully with no complications on 
discharge. 
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DISCUSSION 
Clinical Manifestation and Differential 
Diagnosis 
Leptospirosis usually presents itself as an 
acute febrile illness and mimics several other 
diseases.3 The illness can range from a mild 
infection with symptoms like influenza to 
severe disease. Leptospirosis follows a 
biphasic pattern with an acute septicaemia 
phase which lasts for 1 week.4   Then the 
symptoms resolve when antibodies are 
produced, and the spirochete is excreted in the 
urine.  Three to four days after remission, fever 
may recur which is the second phase of the 
illness. Usually, the illness cannot be clinically 
distinguished from other febrile illness 
syndromes.  In the second phase of the 
disease, a severe form of infection, called 
Weil's syndrome, can happen and is 
characterised by renal failure, bleeding, and 
jaundice.5     
In the acute phase, symptoms vary from fever, 
headache, severe myalgia, anorexia, nausea, 
vomiting and conjunctival suffusion without 
purulent discharge.  The headache in 
leptospirosis is similar to that of dengue fever 
which is characterised by retro-orbital pain and 
photophobia.5   Myalgia is usually in the calf or 
lumbar areas.3 In the second phase of the 
disease, Leptospirosis can affect any organ 
including the brain, liver, kidney, lungs, heart, 
and eyes.  
The differential diagnosis of Leptospirosis is 
vast and must take into consideration all local 
diseases which might present as fever.  
Infections like influenza, malaria, rickettsioses, 
arboviral infections (dengue fever, yellow 
fever, amongst others), Hantavirus, scrub 
typhus  and HIV seroconversion must be 
considered.5-6 Severe fever and haemorrhage 
may make leptospirosis clinically identical to 
viral haemorrhagic fevers.7   
Investigations 
Early diagnosis of leptospirosis is essential.  
General laboratory results are very non-
specific.  One usually finds an increased ESR 
and liver function tests can be slightly 
increased.  Renal function can be impaired.  
Leucocytosis can happen when the infection is 
severe, and platelets have been noted to 
decrease.  Urinalysis can show proteinuria, 
pyuria, and haematuria.5    However, these 
investigations can only give a possible 
diagnosis of leptospirosis.   
Microscopy and culture 
Leptospirosis can be detected by microscopic 
observation of the organism and by isolation 
of the spirochete in cultures.  Body fluids like 
urine, blood, and cerebrospinal fluid (CSF) can 
be seen under dark field microscopy to 
visualise the organism. The timing of the 
sample is crucial.  This method has low 
sensitivity as 1x104 leptospires/ml must be 
present, for leptospires to be seen.3   
Leptospira can be isolated in the acute phase of 
infection.  Cultures from various body fluids 
and tissues can isolate Leptospira.  As with 
direct visualisation, blood cultures can only 
help in the early phase of the illness, meaning 
from before the onset of symptoms to the end 
of the first week, during which leptospiraemia 
happens.  These should be taken before the 
patient takes antibiotics.  Urine cultures can 
also be taken but should be used during the 
leptospirosis phase which is one week after 
onset of symptoms.  Other fluids like CSF and 
peritoneal dialysate can be used to culture 
Leptospira during the first week of infection.  
After, serological methods and molecular 
methods can be used to identify the isolated 
leptospires.4    
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Serological diagnosis 
Detection of specific antibodies and antigens 
can be used to confirm leptospirosis.  
Serological methods can be genus-specific or 
serogroup specific.  The microscopic 
agglutination test (MAT) remains the definite 
serological investigation of choice.  Antibodies 
can be detected in the blood after 5 to 7 days 
after onset of the infection.8   In MAT, the 
patient serum is mixed with leptospiral 
cultures. These are then examined by dark 
field microscopy for agglutination.  MAT 
detects IgG and IgM which are serogroup 
specific.  Therefore, all serogroups should be 
tested. A high titre for a specific serovar 
signifies that it is the cause of the infection.  
For a definite diagnosis, paired sera are 
required.  Some disadvantages of MAT are that 
it is complex, requires maintenance of 
Leptospira cultures and that in the acute phase, 
sensitivity is low.4    
Due to the limitations of MAT, other rapid 
screening tests for the diagnosis of 
leptospirosis in the acute phase have been 
developed.  IgM antibodies can be identified 
during the first week of illness.9   This can be 
done using techniques like ELISA, dipstick, 
lateral flow, indirect hemagglutination assay, 
and latex agglutination.3  However, there are 
still limitations of any serological test in the 
acute phase.  Furthermore, rapid diagnostic 
tests should be confirmed with a reference 
test.10    
Molecular Diagnosis 
DNA detection by polymerase chain reaction 
(PCR) has been applied for the detection of 
Leptospira in the acute setting.  DNA has been 
amplified in several media including blood, 
CSF, urine, aqueous humour, and tissues.11  
PCR has been demonstrated to be useful in the 
detection of Leptospira when antibody 
production has not yet begun.  On the other 
hand, the sensitivity of DNA detection by PCR 
decreases throughout the disease.  A 
limitation of PCR is that it currently cannot 
distinguish between different serovars.12 Real-
time PCR has also been used to quantify 
bacterial load in leptospirosis.13   
In a recent study, investigating the cost-
effectiveness of different management 
concluded that management based on the 
clinical judgement was most efficient.14   
Treatment and Prevention 
Empirical treatment for leptospirosis usually 
consists of penicillin or doxycycline.  
Treatment should be tailored according to 
how severe the infection is, with oral 
antibiotics for a simple febrile illness to IV 
penicillin in severe life-threatening 
infections.15    
Treatment should be started during the early 
stages of diagnosis of leptospirosis and during 
this period oral doxycycline is advised.  In late 
or severe infections (including Weil's disease), 
intravenous penicillin has been shown to 
reduce the length of hospital stay.  Treatment 
should be started as suspicion of leptospirosis 
is made and should be given for a total of 7 
days.  In another study comparing IV penicillin 
G and ceftriaxone, it was shown that there was 
no difference in mortality, therefore, they are 
both equally effective.16   Ciprofloxacin should 
also be given to patients with associated 
uveitis.15    
Leptospira species has a bacterial cell wall.  
Theoretically, this would make it susceptible to 
many different antibiotics. A study in 2003, 
showed that the Leptospira species is 
susceptible in vitro to penicillin, 
cephalosporins, aminoglycosides, macrolides, 
quinolones and tetracyclines amongst others.  
However, leptospira spp. was not shown to be 
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susceptible to metronidazole, glycopeptides, 
sulfamides, and rifampicin.17    
Severe leptospirosis infections can be 
associated with damage to any organ and even 
with multi-organ failure.  Jarisch-Herxheimer 
reactions have also been reported.  Cases with 
acute kidney injury or pulmonary haemorrhage 
(with associated ARDs) sometimes would need 
further treatment with adjunctive therapies 
like haemodialysis and mechanical intubation 
respectively.  Pulmonary leptospirosis is 
usually due to an inflammatory response to 
the leptospires toxin which damages the 
host.15 Corticosteroids can inhibit this 
response but this is still controversial.  A 
review in 2014 noted that a randomised 
control study has shown that these are 
ineffective in pulmonary leptospirosis and can 
even increase the risk for other nosocomial 
infections.  On the other hand, other studies 
showed that pulse dose steroids successfully 
treated leptospiral pulmonary involvement 
and even renal involvement.18-19   
Prophylaxis against leptospirosis with 
doxycycline does not significantly affect the 
incidence of infection but has been shown to 
decrease morbidity and mortality during 
outbreaks of the disease.20 The prevention of 
leptospirosis usually entails better sanitation.  
Leptospirosis is usually carried around by 
rodents, therefore eradication of rodents in 
endemic areas is essential.  Using personal 
protective gear can also prevent infections.   
Vaccinations are also currently available 
against leptospirosis.  The current vaccinations 
are killed, whole-cell suspensions (bacterins).  
These have multiple side effects and have low 
efficacy. Therefore, better vaccines are 
needed.  In these last two decades, new DNA 
vaccines have been promising and are an 
important strategy of minimising leptospirosis 
infection.21   
CONCLUSION 
Leptospirosis is an infectious disease present 
not only in developing countries but also in 
industrialized nations.  Diagnosing 
leptospirosis may be a challenge in view that it 
can mimic several other diseases.  A high index 
of suspicion is needed to make the diagnosis 
based on the history and clinical manifestation 
since laboratory investigations will take days 
to confirm leptospirosis.   
The disease has a biphasic pattern.  Thus, after 
an initial improvement, deterioration in the 
clinical picture with multi-organ failure is not 
uncommon.  Early antibiotic therapy should be 
started in every case of suspected 
leptospirosis since in most cases, early 
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